Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
chia-screen-data-Fav | 2.928 | 1.59e-16 | 1.51e-04 | 1.49e-03 |
Gene Symbol | Entrez Gene ID | Frequency | chia-screen-data-Fav gene score | Best subnetwork score | Degree | Chia-Hits Primary | Chia-Hits Secondary |
---|---|---|---|---|---|---|---|
HCFC1 | 3054 | 40 | -2.925 | 3.449 | 71 | Yes | Yes |
LARS | 51520 | 14 | -2.574 | 3.157 | 105 | Yes | Yes |
EMX1 | 2016 | 4 | -2.369 | 3.216 | 19 | Yes | - |
MED19 | 219541 | 30 | -2.657 | 3.449 | 115 | Yes | - |
[ LINC00305 ] | 221241 | 1 | -1.311 | 2.928 | 1 | - | - |
POLR2D | 5433 | 3 | -1.998 | 3.216 | 36 | - | - |
MED28 | 80306 | 16 | -2.404 | 3.216 | 80 | Yes | - |
MED13L | 23389 | 12 | -2.550 | 3.159 | 21 | Yes | - |
YAP1 | 10413 | 94 | -4.256 | 3.538 | 53 | Yes | - |
POU5F1 | 5460 | 133 | -5.148 | 3.538 | 179 | Yes | Yes |
PSMD2 | 5708 | 47 | -4.172 | 3.157 | 386 | Yes | Yes |
KDM4B | 23030 | 5 | -3.892 | 3.216 | 5 | Yes | - |
LUC7L3 | 51747 | 33 | -3.523 | 3.449 | 18 | Yes | - |
POLR2E | 5434 | 4 | -2.037 | 3.157 | 115 | Yes | - |
SRSF3 | 6428 | 73 | -2.992 | 3.538 | 54 | Yes | - |
RBBP6 | 5930 | 1 | -2.045 | 2.928 | 43 | Yes | - |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
POLR2E | 5434 | MED28 | 80306 | pp | -- | int.I2D: BioGrid |
MED28 | 80306 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct |
EMX1 | 2016 | KDM4B | 23030 | pp | -- | int.I2D: BioGrid_Mouse |
YAP1 | 10413 | MED28 | 80306 | pp | -- | int.I2D: MINT; int.Mint: MI:0915(physical association) |
SRSF3 | 6428 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
POLR2D | 5433 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct |
POU5F1 | 5460 | SRSF3 | 6428 | pp | -- | int.I2D: BioGrid |
HCFC1 | 3054 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
LUC7L3 | 51747 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
POLR2E | 5434 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct |
POLR2D | 5433 | POLR2E | 5434 | pp | -- | int.I2D: BCI, BioGrid, BIND, HPRD; int.Ravasi: -; int.HPRD: in vitro |
POLR2D | 5433 | MED28 | 80306 | pp | -- | int.I2D: BioGrid |
POLR2D | 5433 | RBBP6 | 5930 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
PSMD2 | 5708 | LARS | 51520 | pp | -- | int.I2D: BioGrid_Yeast |
HCFC1 | 3054 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
RBBP6 | 5930 | LINC00305 | 221241 | pp | -- | int.HPRD: yeast 2-hybrid |
EMX1 | 2016 | POLR2D | 5433 | pp | -- | int.I2D: BioGrid; int.Ravasi: - |
MED13L | 23389 | MED28 | 80306 | pp | -- | int.I2D: BioGrid |
MED13L | 23389 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct |
POLR2E | 5434 | LARS | 51520 | pp | -- | int.I2D: YeastLow |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0006366 | transcription from RNA polymerase II promoter | 1.52e-07 | 2.19e-03 | 3.913 | 7 | 30 | 419 |
GO:0016592 | mediator complex | 7.17e-06 | 1.03e-01 | 6.272 | 3 | 10 | 35 |
GO:0010467 | gene expression | 5.23e-05 | 7.54e-01 | 3.015 | 6 | 45 | 669 |
GO:0005654 | nucleoplasm | 8.21e-05 | 1.00e+00 | 2.544 | 7 | 64 | 1082 |
GO:0008380 | RNA splicing | 9.53e-05 | 1.00e+00 | 3.983 | 4 | 22 | 228 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 1.37e-04 | 1.00e+00 | 6.816 | 2 | 4 | 16 |
GO:0003899 | DNA-directed RNA polymerase activity | 3.41e-04 | 1.00e+00 | 6.172 | 2 | 3 | 25 |
GO:0006355 | regulation of transcription, DNA-templated | 4.71e-04 | 1.00e+00 | 2.440 | 6 | 43 | 997 |
GO:0006370 | 7-methylguanosine mRNA capping | 4.93e-04 | 1.00e+00 | 5.909 | 2 | 5 | 30 |
GO:0001104 | RNA polymerase II transcription cofactor activity | 5.97e-04 | 1.00e+00 | 5.772 | 2 | 8 | 33 |
GO:0000398 | mRNA splicing, via spliceosome | 7.25e-04 | 1.00e+00 | 4.043 | 3 | 15 | 164 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.01e-03 | 1.00e+00 | 3.877 | 3 | 22 | 184 |
GO:0050434 | positive regulation of viral transcription | 1.06e-03 | 1.00e+00 | 5.357 | 2 | 5 | 44 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 1 |
GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 1.11e-03 | 1.00e+00 | 9.816 | 1 | 1 | 1 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 1.16e-03 | 1.00e+00 | 5.293 | 2 | 4 | 46 |
GO:0006429 | leucyl-tRNA aminoacylation | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 2 |
GO:0060242 | contact inhibition | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 2 |
GO:0031990 | mRNA export from nucleus in response to heat stress | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 2 | 2 |
GO:0019046 | release from viral latency | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 2 | 2 |
GO:0009786 | regulation of asymmetric cell division | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 2 |
GO:0004823 | leucine-tRNA ligase activity | 2.22e-03 | 1.00e+00 | 8.816 | 1 | 1 | 2 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 2.45e-03 | 1.00e+00 | 4.750 | 2 | 6 | 67 |
GO:0005634 | nucleus | 2.50e-03 | 1.00e+00 | 1.121 | 11 | 159 | 4559 |
GO:0006289 | nucleotide-excision repair | 2.52e-03 | 1.00e+00 | 4.729 | 2 | 5 | 68 |
GO:0060913 | cardiac cell fate determination | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 3.32e-03 | 1.00e+00 | 8.231 | 1 | 1 | 3 |
GO:0051151 | negative regulation of smooth muscle cell differentiation | 4.43e-03 | 1.00e+00 | 7.816 | 1 | 1 | 4 |
GO:0070461 | SAGA-type complex | 5.54e-03 | 1.00e+00 | 7.494 | 1 | 2 | 5 |
GO:0001714 | endodermal cell fate specification | 5.54e-03 | 1.00e+00 | 7.494 | 1 | 1 | 5 |
GO:0021796 | cerebral cortex regionalization | 5.54e-03 | 1.00e+00 | 7.494 | 1 | 1 | 5 |
GO:1990138 | neuron projection extension | 5.54e-03 | 1.00e+00 | 7.494 | 1 | 1 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 2 | 7 |
GO:0001055 | RNA polymerase II activity | 8.84e-03 | 1.00e+00 | 6.816 | 1 | 3 | 8 |
GO:0070688 | MLL5-L complex | 8.84e-03 | 1.00e+00 | 6.816 | 1 | 1 | 8 |
GO:0043254 | regulation of protein complex assembly | 8.84e-03 | 1.00e+00 | 6.816 | 1 | 1 | 8 |
GO:0043995 | histone acetyltransferase activity (H4-K5 specific) | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 5 | 9 |
GO:0046972 | histone acetyltransferase activity (H4-K16 specific) | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 5 | 9 |
GO:0048188 | Set1C/COMPASS complex | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 4 | 9 |
GO:0006450 | regulation of translational fidelity | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 2 | 9 |
GO:0043996 | histone acetyltransferase activity (H4-K8 specific) | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 5 | 9 |
GO:0021895 | cerebral cortex neuron differentiation | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 9 |
GO:0035413 | positive regulation of catenin import into nucleus | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 2 | 10 |
GO:0061053 | somite development | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 1 | 10 |
GO:0001054 | RNA polymerase I activity | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 3 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 4 | 11 |
GO:0005736 | DNA-directed RNA polymerase I complex | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 3 | 12 |
GO:0005838 | proteasome regulatory particle | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 12 |
GO:0045948 | positive regulation of translational initiation | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 12 |
GO:0071480 | cellular response to gamma radiation | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 1 | 13 |
GO:0051213 | dioxygenase activity | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 1 | 13 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 2 | 13 |
GO:0030234 | enzyme regulator activity | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 2 | 13 |
GO:0044212 | transcription regulatory region DNA binding | 1.45e-02 | 1.00e+00 | 3.424 | 2 | 17 | 168 |
GO:0016607 | nuclear speck | 1.52e-02 | 1.00e+00 | 3.390 | 2 | 12 | 172 |
GO:0005685 | U1 snRNP | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 1 | 14 |
GO:0048568 | embryonic organ development | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 1 | 14 |
GO:0043981 | histone H4-K5 acetylation | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 5 | 15 |
GO:0031369 | translation initiation factor binding | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 2 | 15 |
GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 3 | 15 |
GO:0001824 | blastocyst development | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 2 | 15 |
GO:0043982 | histone H4-K8 acetylation | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 5 | 15 |
GO:0048854 | brain morphogenesis | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 2 | 15 |
GO:0006376 | mRNA splice site selection | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 1 | 15 |
GO:0043274 | phospholipase binding | 1.76e-02 | 1.00e+00 | 5.816 | 1 | 1 | 16 |
GO:0042176 | regulation of protein catabolic process | 1.76e-02 | 1.00e+00 | 5.816 | 1 | 2 | 16 |
GO:0001056 | RNA polymerase III activity | 1.76e-02 | 1.00e+00 | 5.816 | 1 | 3 | 16 |
GO:0005666 | DNA-directed RNA polymerase III complex | 1.87e-02 | 1.00e+00 | 5.729 | 1 | 3 | 17 |
GO:0022624 | proteasome accessory complex | 1.87e-02 | 1.00e+00 | 5.729 | 1 | 1 | 17 |
GO:0016032 | viral process | 1.97e-02 | 1.00e+00 | 2.340 | 3 | 26 | 534 |
GO:0006386 | termination of RNA polymerase III transcription | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 3 | 18 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 3 | 18 |
GO:0001701 | in utero embryonic development | 2.04e-02 | 1.00e+00 | 3.165 | 2 | 8 | 201 |
GO:0043984 | histone H4-K16 acetylation | 2.09e-02 | 1.00e+00 | 5.568 | 1 | 5 | 19 |
GO:0000123 | histone acetyltransferase complex | 2.31e-02 | 1.00e+00 | 5.424 | 1 | 6 | 21 |
GO:0045787 | positive regulation of cell cycle | 2.41e-02 | 1.00e+00 | 5.357 | 1 | 2 | 22 |
GO:0001205 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 2.41e-02 | 1.00e+00 | 5.357 | 1 | 4 | 22 |
GO:0030864 | cortical actin cytoskeleton | 2.52e-02 | 1.00e+00 | 5.293 | 1 | 1 | 23 |
GO:0044822 | poly(A) RNA binding | 2.56e-02 | 1.00e+00 | 1.772 | 4 | 50 | 1056 |
GO:0005515 | protein binding | 2.71e-02 | 1.00e+00 | 0.719 | 11 | 198 | 6024 |
GO:0003713 | transcription coactivator activity | 2.77e-02 | 1.00e+00 | 2.927 | 2 | 24 | 237 |
GO:0035329 | hippo signaling | 2.85e-02 | 1.00e+00 | 5.116 | 1 | 5 | 26 |
GO:0071339 | MLL1 complex | 2.96e-02 | 1.00e+00 | 5.061 | 1 | 6 | 27 |
GO:0003727 | single-stranded RNA binding | 3.06e-02 | 1.00e+00 | 5.009 | 1 | 2 | 28 |
GO:0000166 | nucleotide binding | 3.27e-02 | 1.00e+00 | 2.799 | 2 | 13 | 259 |
GO:0006360 | transcription from RNA polymerase I promoter | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 3 | 30 |
GO:0006281 | DNA repair | 3.31e-02 | 1.00e+00 | 2.788 | 2 | 14 | 261 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 3.38e-02 | 1.00e+00 | 2.772 | 2 | 23 | 264 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 3.49e-02 | 1.00e+00 | 4.816 | 1 | 2 | 32 |
GO:0006383 | transcription from RNA polymerase III promoter | 4.24e-02 | 1.00e+00 | 4.531 | 1 | 3 | 39 |
GO:0035019 | somatic stem cell maintenance | 4.35e-02 | 1.00e+00 | 4.494 | 1 | 6 | 40 |
GO:0006418 | tRNA aminoacylation for protein translation | 4.56e-02 | 1.00e+00 | 4.424 | 1 | 3 | 42 |
GO:0031124 | mRNA 3'-end processing | 4.56e-02 | 1.00e+00 | 4.424 | 1 | 2 | 42 |
GO:0006369 | termination of RNA polymerase II transcription | 4.88e-02 | 1.00e+00 | 4.324 | 1 | 2 | 45 |
GO:0019827 | stem cell maintenance | 5.09e-02 | 1.00e+00 | 4.261 | 1 | 7 | 47 |
GO:0006521 | regulation of cellular amino acid metabolic process | 5.41e-02 | 1.00e+00 | 4.172 | 1 | 1 | 50 |
GO:0043565 | sequence-specific DNA binding | 5.52e-02 | 1.00e+00 | 2.381 | 2 | 11 | 346 |
GO:0009611 | response to wounding | 5.62e-02 | 1.00e+00 | 4.116 | 1 | 5 | 52 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 5.72e-02 | 1.00e+00 | 4.088 | 1 | 4 | 53 |
GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 5.83e-02 | 1.00e+00 | 4.061 | 1 | 3 | 54 |
GO:0000932 | cytoplasmic mRNA processing body | 5.83e-02 | 1.00e+00 | 4.061 | 1 | 4 | 54 |
GO:0005925 | focal adhesion | 6.10e-02 | 1.00e+00 | 2.300 | 2 | 9 | 366 |
GO:0000502 | proteasome complex | 6.25e-02 | 1.00e+00 | 3.958 | 1 | 3 | 58 |
GO:0032481 | positive regulation of type I interferon production | 6.56e-02 | 1.00e+00 | 3.885 | 1 | 6 | 61 |
GO:0006406 | mRNA export from nucleus | 6.56e-02 | 1.00e+00 | 3.885 | 1 | 4 | 61 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 6.87e-02 | 1.00e+00 | 3.816 | 1 | 1 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 6.98e-02 | 1.00e+00 | 3.794 | 1 | 2 | 65 |
GO:0035264 | multicellular organism growth | 7.18e-02 | 1.00e+00 | 3.750 | 1 | 2 | 67 |
GO:0010468 | regulation of gene expression | 7.29e-02 | 1.00e+00 | 3.729 | 1 | 2 | 68 |
GO:0003697 | single-stranded DNA binding | 7.29e-02 | 1.00e+00 | 3.729 | 1 | 5 | 68 |
GO:0005694 | chromosome | 7.49e-02 | 1.00e+00 | 3.687 | 1 | 2 | 70 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 7.49e-02 | 1.00e+00 | 3.687 | 1 | 2 | 70 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 7.70e-02 | 1.00e+00 | 3.646 | 1 | 1 | 72 |
GO:0003729 | mRNA binding | 7.70e-02 | 1.00e+00 | 3.646 | 1 | 4 | 72 |
GO:0009791 | post-embryonic development | 7.80e-02 | 1.00e+00 | 3.626 | 1 | 3 | 73 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 7.90e-02 | 1.00e+00 | 3.607 | 1 | 4 | 74 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 7.90e-02 | 1.00e+00 | 3.607 | 1 | 2 | 74 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 8.01e-02 | 1.00e+00 | 3.587 | 1 | 1 | 75 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 8.42e-02 | 1.00e+00 | 3.512 | 1 | 2 | 79 |
GO:0009653 | anatomical structure morphogenesis | 8.82e-02 | 1.00e+00 | 3.441 | 1 | 2 | 83 |
GO:0050821 | protein stabilization | 9.33e-02 | 1.00e+00 | 3.357 | 1 | 3 | 88 |
GO:0005737 | cytoplasm | 9.70e-02 | 1.00e+00 | 0.744 | 7 | 124 | 3767 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 9.74e-02 | 1.00e+00 | 3.293 | 1 | 1 | 92 |
GO:0016568 | chromatin modification | 1.03e-01 | 1.00e+00 | 3.201 | 1 | 4 | 98 |
GO:0005815 | microtubule organizing center | 1.14e-01 | 1.00e+00 | 3.048 | 1 | 3 | 109 |
GO:0000209 | protein polyubiquitination | 1.21e-01 | 1.00e+00 | 2.958 | 1 | 3 | 116 |
GO:0006325 | chromatin organization | 1.23e-01 | 1.00e+00 | 2.933 | 1 | 12 | 118 |
GO:0005829 | cytosol | 1.28e-01 | 1.00e+00 | 0.853 | 5 | 86 | 2496 |
GO:0003677 | DNA binding | 1.48e-01 | 1.00e+00 | 1.151 | 3 | 49 | 1218 |
GO:0010628 | positive regulation of gene expression | 1.50e-01 | 1.00e+00 | 2.626 | 1 | 7 | 146 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.53e-01 | 1.00e+00 | 2.597 | 1 | 3 | 149 |
GO:0042981 | regulation of apoptotic process | 1.54e-01 | 1.00e+00 | 2.587 | 1 | 4 | 150 |
GO:0006974 | cellular response to DNA damage stimulus | 1.55e-01 | 1.00e+00 | 2.578 | 1 | 7 | 151 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.74e-01 | 1.00e+00 | 2.398 | 1 | 2 | 171 |
GO:0007049 | cell cycle | 1.77e-01 | 1.00e+00 | 2.373 | 1 | 6 | 174 |
GO:0005667 | transcription factor complex | 1.78e-01 | 1.00e+00 | 2.365 | 1 | 17 | 175 |
GO:0031625 | ubiquitin protein ligase binding | 1.80e-01 | 1.00e+00 | 2.340 | 1 | 5 | 178 |
GO:0003714 | transcription corepressor activity | 1.80e-01 | 1.00e+00 | 2.340 | 1 | 11 | 178 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 1.80e-01 | 1.00e+00 | 1.367 | 2 | 39 | 699 |
GO:0016874 | ligase activity | 2.13e-01 | 1.00e+00 | 2.075 | 1 | 4 | 214 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 2.17e-01 | 1.00e+00 | 1.192 | 2 | 41 | 789 |
GO:0016071 | mRNA metabolic process | 2.21e-01 | 1.00e+00 | 2.015 | 1 | 8 | 223 |
GO:0008134 | transcription factor binding | 2.37e-01 | 1.00e+00 | 1.897 | 1 | 18 | 242 |
GO:0043025 | neuronal cell body | 2.40e-01 | 1.00e+00 | 1.879 | 1 | 9 | 245 |
GO:0016070 | RNA metabolic process | 2.42e-01 | 1.00e+00 | 1.868 | 1 | 8 | 247 |
GO:0004842 | ubiquitin-protein transferase activity | 2.48e-01 | 1.00e+00 | 1.822 | 1 | 5 | 255 |
GO:0003779 | actin binding | 2.58e-01 | 1.00e+00 | 1.761 | 1 | 10 | 266 |
GO:0005730 | nucleolus | 2.71e-01 | 1.00e+00 | 0.721 | 3 | 66 | 1641 |
GO:0042493 | response to drug | 2.73e-01 | 1.00e+00 | 1.666 | 1 | 6 | 284 |
GO:0016020 | membrane | 2.84e-01 | 1.00e+00 | 0.686 | 3 | 46 | 1681 |
GO:0008270 | zinc ion binding | 3.04e-01 | 1.00e+00 | 0.855 | 2 | 27 | 997 |
GO:0003682 | chromatin binding | 3.07e-01 | 1.00e+00 | 1.463 | 1 | 19 | 327 |
GO:0008283 | cell proliferation | 3.08e-01 | 1.00e+00 | 1.459 | 1 | 14 | 328 |
GO:0030054 | cell junction | 3.14e-01 | 1.00e+00 | 1.424 | 1 | 5 | 336 |
GO:0003723 | RNA binding | 3.19e-01 | 1.00e+00 | 1.398 | 1 | 18 | 342 |
GO:0000278 | mitotic cell cycle | 3.56e-01 | 1.00e+00 | 1.205 | 1 | 15 | 391 |
GO:0055114 | oxidation-reduction process | 3.77e-01 | 1.00e+00 | 1.102 | 1 | 10 | 420 |
GO:0043066 | negative regulation of apoptotic process | 3.80e-01 | 1.00e+00 | 1.088 | 1 | 16 | 424 |
GO:0042802 | identical protein binding | 4.21e-01 | 1.00e+00 | 0.897 | 1 | 19 | 484 |
GO:0006915 | apoptotic process | 4.66e-01 | 1.00e+00 | 0.700 | 1 | 12 | 555 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 4.76e-01 | 1.00e+00 | 0.661 | 1 | 37 | 570 |
GO:0006351 | transcription, DNA-templated | 4.87e-01 | 1.00e+00 | 0.318 | 2 | 57 | 1446 |
GO:0045087 | innate immune response | 4.91e-01 | 1.00e+00 | 0.597 | 1 | 15 | 596 |
GO:0005576 | extracellular region | 6.61e-01 | 1.00e+00 | -0.063 | 1 | 13 | 942 |
GO:0005739 | mitochondrion | 6.83e-01 | 1.00e+00 | -0.147 | 1 | 23 | 998 |
GO:0044281 | small molecule metabolic process | 7.54e-01 | 1.00e+00 | -0.426 | 1 | 20 | 1211 |
GO:0005524 | ATP binding | 7.79e-01 | 1.00e+00 | -0.526 | 1 | 31 | 1298 |
GO:0070062 | extracellular vesicular exosome | 9.46e-01 | 1.00e+00 | -1.413 | 1 | 57 | 2400 |
GO:0005886 | plasma membrane | 9.57e-01 | 1.00e+00 | -1.518 | 1 | 49 | 2582 |